BackHillstream BioPharma Overview

Hillstream BioPharma Profit Margin

Valuation check: HILS's profit margin is -6559.27%, below the sector sector average of 22.52%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-1287.21%

As of Jun 2026

Annual Profit Margin (TTM)

-6559.27%

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Hillstream BioPharma (HILS) FAQ

As of the most recent data (June 2026), HILS shows a profit margin of -6559.27%. That is below the sector sector average of 22.52%. Scroll down for historical charts and peer comparison views.

The its sector sector average profit margin is about 22.52%. Hillstream BioPharma is at -6559.27%, which is lower that average. That is roughly 29225.9% below the sector mean. Use the comparison chart on this page to see how HILS stacks up against individual peers as well.

Check the historical chart to see whether HILS's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Hillstream BioPharma with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Hillstream BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -6559.27%) with ownership activity and broader fundamentals.